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Objectives: Granulocyte-colony stimulating factor (G-CSF) plays important roles in neuroprotection.
Acute and massive increases in extracellular dopamine can cause damage to the striatal neurons during
cerebral ischemia (CI). We hypothesized that G-CSF may exert neuroprotective effects by reducing
dopamine accumulation.
Materials and Methods: CI was induced by infusing endothelin-1 (Et-1, 120 pmol in 10 mL saline) into the
root of the middle cerebral artery in freely moving rats. G-CSF (200 mg/kg in 0.2 mL saline) was
administered immediately after CI induction.
Results: G-CSF reduced dopamine accumulation in the ischemic striatum after CI was induced by Et-1.
The total brain infarct volume was reduced by 67% (p < 0.05) at 24 hours after CI.
Conclusion: These data suggest that reduced dopamine accumulation may be one of the mechanisms
underlying the neuroprotective effects of G-CSF.
Copyright  2012, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Granulocyte-colony stimulating factor (G-CSF) exerts neuro-
protection and helps in tissue repair after cerebral ischemia (CI) [1e
3]. The underlying mechanisms of its neuroprotection include
mobilization of stem cells, neuronal differentiation, angiogenesis,
and anti-inﬂammatory and antiapoptotic effects [1e3]. Moreover,
G-CSF can exert neuroprotective effects by reducing excitotoxicity
caused by glutamate overﬂow in the ischemic brain [4]. Overﬂow of
generalized neurotransmitters after CI contributes to subsequent
neuronal death. Dopamine is an important neurotransmitter. It is
dramatically released or accumulated in the striatum [5,6] to cause
signiﬁcant damage to neurons during CI [7,8]. Acute and massive
increases in extracellular dopamine and glutamate concentrations
have been documented in the striatum after CI [9]. Reduction of
dopamine accumulation alleviates cerebral damage [7]. Moreover,Research, Buddhist Tzu Chi
ualien, Taiwan. Tel.: þ886 3
g).
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against postischemic striatal neuronal death [8,10]. These results
indicate the role of dopamine- and glutamate-induced excitotox-
icity in ischemic neuronal cell death. However, sustained auto-
oxidation of dopamine may lead to an excessive accumulation of
quinones and oxygen free radicals [11]. Based on these ﬁndings, we
hypothesized that G-CSF may also exert neuroprotective effect by
reducing dopamine accumulation.2. Materials and methods
2.1. Animals
The experimental animals were handled according to the
National Institutes of Health Guide for the Care and Use of Laboratory
Animals, and experimental protocols were approved by the Animal
Use Protocol Board of Tzu Chi Hospital (Approval No. 97-22).
Animals were housed under a 12-hour light/dark cycle, with free
access to food and water. Every effort was made to minimize the
number of animals necessary to complete the study and their
suffering, and the study was in compliance with the guidelines.Foundation. Published by Elsevier Taiwan LLC. All rights reserved.
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Rats were assigned randomly to four experimental groups:
sham þ saline (n ¼ 3), sham þ G-CSF (n ¼ 6), ischemia þ saline
(n ¼ 10), and ischemia þ G-CSF (n ¼ 11) groups (Fig. 1A).
2.3. Cannula implantation
For guide cannula implantation, rats were anesthetized with 5%
isoﬂurane for initiation and 2.5% for maintenance. Using standard
stereotaxic techniques, two intracerebral guide cannulas, one for
a microdialysis probe and the other for endothelin-1 (Et-1)
delivery, were implanted. The coordinates of the microdialysis
probe cannula were 0.0 mm posterior, 3.0 mm right, and 5.0 mm
ventral to bregma at the skull surface, and those of the Et-1 delivery
27-gauge syringe cannulawere 0.0mmposterior, 5.2mm right, andFig. 1. (A) Schematic diagrams of microdialysis in freely moving rats. (B) A proﬁle of the repr
Et-1 ¼ endothelin-1; G-CSF ¼ granulocyte-colony stimulating factor; 5-HIAA ¼ 5-hydro
hydroxytryptamine; HVA ¼ homovanillic acid.8.0 mmventral to bregma at the skull surface. These cannulas were
implanted and ﬁxed to the skull with dental cement. Animals were
allowed to recover from surgery for at least 5 days (Fig. 1A) prior to
CI induction.
2.4. CI induction
The CI procedure was modiﬁed from a previously published
procedure [12]. CI was created by infusion of Et-1 (120 pmol in
10 mL saline at 1 mL/min; Sigma, St Louis, MO, USA) through a 27-
gauge syringe positioned in proximity to the root of the middle
cerebral artery [5]. The needle was kept in place for another 10
minutes to prevent backﬂow. G-CSF (200 mg/kg in 0.5 mL saline;
Kirin Pharma Co., Ltd, Tokyo, Japan) was administered (subcuta-
neously) immediately after the infusion of Et-1. Vehicle control for
G-CSF was 0.5 mL saline (Fig. 1A).esentative catecholamines in striatal tissues. DOPAC ¼ 3,4-dihydroxyphenylacetic acid;
xyindoleacetic acid; HPLC ¼ high-performance liquid chromatography; 5-HT ¼ 5-
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To avoid interference by anesthetic drugs on the striatal
neurotransmitter proﬁle, microdialysis was conducted in freely
moving rats (Fig. 1A). Brieﬂy, on the day of the experiment,
a microdialysis probe (CMA/12, cut-off 20 kDa and membrane
length 3 mm; Carnegie Medicine, Stockholm, Sweden) and a 27-
gauge syringe for induction of CI were inserted. The striatal tissue
were perfused with an aseptic modiﬁed artiﬁcial cerebrospinal
ﬂuid (pH ¼ 7.4), consisting of 125 mM NaCl, 5 mM KCl, 2 mM
CaCl2$2H2O, 1.14 mM MgSO4$7H2O, 1.29 mM KH2PO4, 25 mM
NaHCO3, and 0.1 mM ascorbic acid,. The perfusion rate was set at
1 mL/min. After a stabilizing period of 1 hour, microdialysates
(30 mL) from each 30-minute period were collected in sample tubes
containing 2.5 mL 3.3% perchloric acid, mixed vigorously, and
centrifuged, and the supernatant was analyzed immediately by
high-performance liquid chromatography (HPLC) using an MF-
1020 (Bioanalytical Systems, West Lafayette, IN, USA) electrode
chemical detector (ECD).
2.6. HPLC-ECD analysis
The ﬁrst and second microdialysate samples were pooled for
quantiﬁcation of the basal catecholamine concentration prior to CI.
The microdialysates (20 mL) were separated and quantiﬁed by
HPLC-ECD. The mobile phase (100 mM NaH2PO4, 0.75 mM sodium
octane sulfonate, 0.027 mM EDTA$2H2O, and 10% methanol;
pH ¼ 3.0, adjusted with phosphoric acid) was ﬁltered through
a 0.2 mm cellulose nitrate ﬁlter (Gelman Sciences, Ann Arbor, MI,
USA) and degassed under vacuum prior to use. This mobile phase
was set at a ﬂow rate of 0.2 mL/min (pump: PM-92E; BAS
Instruments, West Lafayette, IN, USA). A Vision HT Hypersil
column (C18 3m, 2.1  100 mM2; Grace, Deerﬁeld, IL, USA) was
used for separation. The recovery rate of all microdialysis probes
in vitro was in the range of 20%  5%, and the probes were cali-
brated with known amounts of standards. All standards [norepi-
nephrine, epinephrine, 3,4-dihydroxyphenylacetic acid (DOPAC),
dopamine, 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid
(HVA), and 5-hydroxytryptamine (5-HT)] were purchased from
Sigma. The concentrations of all catecholamines were calculated
using standard curves constructed with known amounts of stan-
dards (Fig. 1B). The minimum detectable level of the catechol-
amines was 5 nM.
2.7. Total infarction volume
Rats were decapitated under deep anesthesia at 24 hours after
CI. The brain was removed, and the forebrain was sliced into 1-
mm-thick coronal sections and stained with 2% 2,3,5-
triphenyltetrazolium (Sigma) for 20 minutes at 37C in the dark.
The total infarction volume was determined using Image J soft-
ware (NIH, Bethesda, MD, USA). These sections were also used for
the veriﬁcation of correct positions of the Et-1 infusion and
microdialysis probes.
2.8. Statistical analysis
Datawere statistically analyzed using Prism software (GraphPad
Software, Inc., La Jolla, CA, USA) for the Student t test and were
presented as mean  standard error of the mean (SEM). Statistical
comparisons among multiple groups were made using one-way
analysis of variance (ANOVA), and among multiple time points
using two-way ANOVA followed by the Bonferroni correction. In all
instances, n referred to the number of animals in a particular group.
A p value of <0.05 was considered statistically signiﬁcant.3. Results
The systemic blood pressure and heart rate were not affected in
all rats subjected to infusion of Et-1 or subcutaneous administration
of G-CSF. The basal extracellular concentration of the striatal dopa-
mine was 14.7  2.0 nM. The extracellular concentration of dopa-
mine in the striatum increased to a maximum (240  83-folds) at 1
hour after CI (Fig. 2A, ischemia þ saline group vs. sham þ saline
group). G-CSF treatment signiﬁcantly suppressed the increase in
dopamine to 41  20-fold (Fig. 2A, ischemia þ G-CSF group vs.
shamþ saline group), while G-CSF or saline alone did not affect the
basal dopamine level (Fig. 2A). Themetabolites of dopamine (DOPAC
andHVA) and serotonin (5-HIAA)were signiﬁcantly decreased after
CI, but were not affected by G-CSF administration (Fig. 2BeD)
compared with the saline-treated group (ischemia þ saline group)
(Fig. 2BeD).
The average cerebral infarction volume in the rats of the
ischemia þ saline group was 171 mm3, whereas the cerebral
infarction volume of the G-CSF-treated CI rats was reduced to
57 mm3 (67% reduction) (Fig. 3).
4. Discussion
This study demonstrated for the ﬁrst time that G-CSF treatment
signiﬁcantly reduces dopamine accumulation, which in turn
reduces the total cerebral infarction volume in animals with Et-1-
induced CI.
Striatal tissues are perceived to be affected differentially by
ischemia, with a more vulnerable ischemic core and a compro-
mised but relatively more salvageable peri-infarct zone [13,14].
However, salvageability decreases with time, making speedy and
effective therapeutic intervention critical. In various ischemic
models, the susceptibility of the striatum to ischemia has been
found to be associated with dopamine accumulation [8,10,15e18].
Dopamine is widely recognized as a potential neurotoxic trans-
mitter that contributes to subsequent neuronal damage after
ischemiaereperfusion [7,8,19]. A rapid accumulation of extracel-
lular dopamine, rather than the slower glutamate overﬂow, is likely
the primary event initiating a cascade that ultimately leads to cell
death and neurological deﬁcits [5]. In contrast, dopamine deple-
tion, either by pharmacological or by surgical means, improves the
ischemic outcome in the striatum [7,8]. In agreement with those
ﬁndings, our results demonstrated that G-CSF reduces dopamine
accumulation and contributes, at least in part, to the reduction of
the total cerebral infarction volume in rats with Et-1-induced CI.
The changes in dopamine metabolites and serotonin were less
profound.
G-CSF can penetrate the bloodebrain barrier even in the intact
brain [20]. The underlying mechanisms contributing to the reduc-
tion of dopamine accumulation in vivo by G-CSF are unclear. The
excessive increase in extracellular dopamine, which occurs during
ischemia, is probably a result of cell destruction rather than of
secretion. However, secretion of dopamine may also increase cere-
bral glucose utilization, which in turn contributes to an increase in
cerebral energy demand during ischemia. As a consequence, brain
tissues are affected by both stresses during CI, which may lead to
greater secondary damage. Therefore, reduction in dopamine
accumulation by G-CSF may be one of the mechanisms by which G-
CSF can reduce infarct volume.
In our CI model, the total infarction volume covered both the
cortex and the striatum (Fig. 3). However, the speciﬁc mechanism
that caused reduced cortical infarction is unknown. A plausible
explanation is that the reduction in the cortical infarction volume is
due to G-CSF potentials in anti-inﬂammation, antiapoptotic cell
death, and stem cell activation/recruitment [21,22].
Fig. 2. Effects of G-CSF on catecholamine concentrations in microdialysates collected from the striatum subjected to CI: (A) dopamine; (B) DOPAC; (C) 5-HIAA; (D) HVA. Time
0 refers to Et-1 infusion. The value at time 0 indicates the baseline concentration. *p<0.05 for the ischemia þ saline group compared with sham þ saline group. Data are expressed
as fold increase compared with the baseline concentration (mean  SEM). CI ¼ cerebral ischemia; DOPAC ¼ 3,4-dihydroxyphenylacetic acid; Et-1 ¼ endothelin-1;
G-CSF ¼ granulocyte-colony stimulating factor; 5-HIAA ¼ 5-hydroxyindoleacetic acid; HVA ¼ homovanillic acid.
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Fig. 3. (A) Effects of G-CSF (200 mg/kg, subcutaneous) on the infarct volume caused by CI. (B) Rats were killed 24 hours after the infusion of Et-1. The infarct volume was determined
using Image J software on the seven predetermined coronal planes through the brain as shown in (A). Statistical analysis showed signiﬁcant reduction of infarct volume in G-CSF
treated brains: *p<0.05 between the two groups. Data are presented as mean  SEM. CI ¼ cerebral ischemia; Et-1 ¼ endothelin-1; G-CSF ¼ granulocyte-colony stimulating factor.
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The actual neuroprotective mechanism(s) of G-CSF awaits
further investigation. However, the major advantage of this protein
is that it has a well-known pharmacological proﬁle and safety
record, and thus many clinical trials have been carried out using G-
CSF as a therapeutic agent (please search “G-CSF” in http://www.
clinicaltrials.gov for details). Because G-CSF exerts neuro-
protective effects through reduction of excitotoxicity caused by
glutamate overﬂow in the ischemic brain [4], we conclude that G-
CSF can also reduce dopamine overﬂowand exert a neuroprotective
effect on striatal neuronal cells after CI.
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